US 12239729
TRPV3 agonists for the treatment of skin conditions
granted A61KA61K38/08A61K38/10
Quick answer
US patent 12239729 (TRPV3 agonists for the treatment of skin conditions) held by Soricimed Biopharma Inc. expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Soricimed Biopharma Inc.
- Grant date
- Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K38/08, A61K38/10, A61K38/17, A61K38/1709